Ignite Creation Date:
2024-05-06 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03548818
Status:
COMPLETED
Last Update Posted:
2021-01-22
First Post:
2018-03-20
Brief Title:
Role of Interferon-gamma 1-b IFN-γ on Cells of the Innate Immune System Functional Biochemical and Gene Expression Studies in Patients With Chronic Granulomatous Disease
Sponsor:
University of Colorado Denver
Organization:
University of Colorado Denver
Study Overview
Official Title:
Role of Interferon-gamma 1-b IFN-γ on Cells of the Innate Immune System Functional Biochemical and Gene Expression Studies in Patients With Chronic Granulomatous Disease
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The overall goal of the study is to investigate the functional biochemical and gene expression effects of Interferon-gamma 1-b IFN-γ on the neutrophils of patients with Chronic Granulomatous Disease CGD The investigators hypothesize that the clinical effects demonstrated in patients with CGD treated with IFN-γ decreased number and severity of infections are the result of biochemical processes and upregulation of specific genes which lead to enhanced functionality of this immune cell population
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None